<DOC>
	<DOCNO>NCT01334294</DOCNO>
	<brief_summary>ForeseeHome , FDA-approved home device , specifically design unsupervised Preferential-Hyperacuity-Perimeter ( PHP ) test Age Related Macular Degeneration ( AMD ) patient home characterize central paracentral metamorphopsia . The purpose current study evaluate , post-treatment patient , PHP parameter measure ForeseeHome agreement clinical decision retinal characteristic measure optical coherence tomography ( OCT ) .</brief_summary>
	<brief_title>Home Vision Monitoring Using ForeseeHome Device Following Treatment Neovascular Age Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<criteria>1 . Received intravitreal antiangiogenic therapy CNV study eye ( SE ) , within 212 month prior study 2 . Last diagnosis , current diagnosis , CNV activity SE eye 3 . Current plan SE clinical examination standard care interval 8 week . 4 . Visual acuity 20/80 good SE 5 . Are capable agree sign consent form participate study 6 . Age &gt; 55 year age 7 . Are able use standard computer mouse correctly without assistance 8 . Have work telephone landline main residence ( cellular communication maybe available study , eliminate requirement ) 9 . Clear view macular area fundus photography 10 . Are willing give name contact information Notal Vision , supplier device , company provide direct service need ( e.g. , assist use home device , report frequency usage , coordinate replacement device case technical problem , etc . ) 11 . Agree examine ophthalmologist SE show symptom change study 12 . Have US address plan travel abroad study period 13 . Fluent English 14 . Perform reliable ForeseeHome test enrollment visit 1 . Evidence macular disease AMD glaucoma SE 2 . Presence significant medium opacity precludes clear view macular area identify SE biomicroscopy 3 . Any nonmacular related ocular surgery perform within 3 month prior study entry SE 4 . Participant enrol another stuy could affect interval clinical examination , frequency use ForeseeHome device</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>CNV</keyword>
	<keyword>AMD</keyword>
</DOC>